Fluorouracil is a prescription drug available from your pharmacy store only with the prescription of a qualified medical practitioner.
Fluorouracil is pronounced as: FLURE-oh-UE-ra-sil
Fluorouracil is an anti cancer drug belongs to anti metabolite group of drugs.
Fluorouracil is used in the treatment of various types of cancer. Topical solution or cream is used to treat superficial basal cell carcinoma.
Pregnant woman: Fluorouracil belongs to FDA pregnancy category X. This means that fluorouracil will cause birth defects if used during pregnancy. The use of this drug in pregnancy clearly outweighs any possible benefit. Do not use fluorouracil if you are pregnant or are planning for conception.
Fluorouracil is available in the form of injection, tablets and cream.
Use fluorouracil as directed by your physician, your physician prescribes depending on the severity of disease. Use the complete course of medication as prescribed by your physician even though you feel better after one or two days of usage of medication.
If it is almost the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not take two doses of fluorouracil at same time to cover up the missed dose.
In case of overdose of fluorouracil contact your nearest poison control centre or emergency medical centre for immediate care by physician.
The following are the side effects you may experience with fluorouracil
If you experience any of the following side affects stop the fluorouracil medication and consult your doctor immediately
Allergic reactions like difficult breathing, skin rashes, hives, swelling of face, lips
Store fluorouracil at room temp (15 – 30 degrees C). Avoid excessive heat, moisture or direct sunlight, never store in the bathroom.
Keep it out of reach of children. Make sure that any leftover portion is disposed off safely.
It is imp to read manufacturing packaging instruction carefully if available and always do not hesitate to consult pharmacist or physician for any information.
Written by: healthplus24 team
Date last updated: May 31, 2012
Subscribe to our email newsletter.